Juho T. Eineluoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Juho T. Eineluoto has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Jutta H. Jokinen
Department of Urology, Hyvinkää Hospital, Hyvinkää, FIN
1 shared publicationJutta Jokinen
Department of Urology, Hyvinkää Hospital, Hyvinkää, FIN
1 shared publication
Latest Publications
- Open Access
- 13 August 2025
- Published by Springer Nature in Cureus
- Vol. 17 (8) , e90013
Silent but Severe: A Case Report of a Large Retroperitoneal Hematoma Following Routine Intradetrusor Botulinum Toxin A Injections
Intravesical botulinum toxin A injections are an established and generally well-tolerated treatment for an overactive bladder. Major complications are uncommon. We report a rare case of a substantial retroperitoneal hematoma following routine intradetrusor botulinum toxin administration. A 53-year-old female with a diagnosis of multiple sclerosis was treated at the urology outpatient clinic for neurogenic bladder symptoms. Four days after the injections, she presented to the emergency department with lower abdomen pain, hematuria, urinary retention, and a visible hematoma around the umbilicus (Cullen’s sign). Her hemoglobin level had decreased from 123 g/L to 107 g/L. A CT scan revealed a large pelvic retroperitoneal hematoma measuring 11 × 5 × 5 cm, attributed to the injections. She was managed conservatively. A follow-up CT scan two months later demonstrated a reduction in the size of the hematoma.
- 13 August 2025
- Published by Springer Nature in Cureus
- Vol. 17 (8) , e90013
Open AccessSilent but Severe: A Case Report of a Large Retroperitoneal Hematoma Following Routine Intradetrusor Botulinum Toxin A Injections
Intravesical botulinum toxin A injections are an established and generally well-tolerated treatment for an overactive bladder. Major complications are uncommon. We report a rare case of a substantial retroperitoneal hematoma following routine intradetrusor botulinum toxin administration. A 53-year-old female with a diagnosis of multiple sclerosis was treated at the urology outpatient clinic for neurogenic bladder symptoms. Four days after the injections, she presented to the emergency department with lower abdomen pain, hematuria, urinary retention, and a visible hematoma around the umbilicus (Cullen’s sign). Her hemoglobin level had decreased from 123 g/L to 107 g/L. A CT scan revealed a large pelvic retroperitoneal hematoma measuring 11 × 5 × 5 cm, attributed to the injections. She was managed conservatively. A follow-up CT scan two months later demonstrated a reduction in the size of the hematoma.